Report error Found 140 Enz. Inhib. hit(s) with all data for entry = 11645
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 750nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 770nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 870nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 890nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 960nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 990nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.03E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.03E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.03E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.03E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.06E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.07E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.15E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.15E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.16E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.18E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.19E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.20E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.23E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.24E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.25E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.30E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.31E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.33E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.35E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.37E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.40E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.42E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.44E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.47E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.48E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.49E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.49E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.51E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.54E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.59E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.60E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.62E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.63E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.63E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.67E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.68E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.73E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.75E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.77E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.78E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.79E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase PLK1(Human)
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
The United States of America,As Represented By The Secretary,Department of Health and Human Services
US Patent
Affinity DataIC50: 1.83E+3nMAssay Description:An ELISA-based PBD-binding inhibition assay was performed essentially as described previously. Briefly, a biotinylated PBIP1 p-T78 peptide (i.e., Bio...More data for this Ligand-Target Pair
